A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder

Meta-analysis in clinical trials

1986 • 36,193 citations

A RATING SCALE FOR DEPRESSION

1960 • 30,921 citations

A New Depression Scale Designed to be Sensitive to Change

1979 • 12,729 citations

Publication and related bias in meta-analysis

2000 • 1,976 citations

DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION

1996 • 764 citations

Some Statistical Methods for Combining Experimental Results

1990 • 579 citations

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis

2002 • 544 citations

Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study

1990 • 390 citations

Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients

2002 • 358 citations

Duloxetine in the Treatment of Depression

2004 • 317 citations

Similar Effectiveness of Paroxetine, Fluoxetine, and Sertraline in Primary Care

2001 • 310 citations

Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study

1986 • 294 citations

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

2000 • 259 citations

Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

2003 • 220 citations

Understanding Research Synthesis (Meta-Analysis)

1996 • 212 citations

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

2005 • 190 citations

A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients

2000 • 169 citations

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

2000 • 134 citations

Milnacipran and selective serotonin reuptake inhibitors in major depression

1996 • 125 citations

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression

1993 • 118 citations

Empirical Testing of Two Models for Staging Antidepressant Treatment Resistance

2005 • 111 citations

A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.

1995 • 106 citations

Sertraline Versus Paroxetine in Major Depression: Clinical Outcome After Six Months of Continuous Therapy

2000 • 100 citations

A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice

1997 • 96 citations

Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice

1996 • 87 citations

Comparative Efficacy of Sertraline vs. Fluoxetine in Patients Age 70 or Over With Major Depression

1999 • 73 citations

Biology of Depression

2005 • 71 citations

Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine

2001 • 66 citations

Controlled comparison of milnacipran and fluoxetine in major depression

1994 • 62 citations

A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients

1999 • 59 citations

A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients

1998 • 57 citations

A comparative study of milnacipran and paroxetine in outpatients with major depression

2004 • 45 citations

Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients

1996 • 45 citations

Efficacy and Response Time to Sertraline Versus Fluoxetine in the Treatment of Unipolar Major Depressive Disorder

2000 • 29 citations

Interest of a loading dose of milnacipran in endogenous depressive inpatients

1991 • 24 citations

Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression

2005 • 23 citations